World's Best Scientists 2026 revealed!
Masafumi Fukagawa

Masafumi Fukagawa

D-Index & Metrics

Medicine

D-Index
80
Citations
24030
World Ranking
17088
National Ranking
543

Overview

Masafumi Fukagawa is affiliated with Tokai University in Japan and has contributed extensively to the field of medicine, particularly focusing on nephrology. Their research portfolio includes numerous publications addressing various aspects of kidney disease and related disorders.

The primary subfields of study associated with their work are:

  • Nephrology
  • Pulmonary and Respiratory Medicine
  • Genetics
  • Nutrition and Dietetics
  • Pathology and Forensic Medicine

Masafumi Fukagawa's research topics cover key areas in kidney health and disease management, including:

  • Parathyroid Disorders and Treatments
  • Dialysis and Renal Disease Management
  • Potassium and Related Disorders
  • Magnesium in Health and Disease
  • Vitamin D Research Studies
  • Pharmacological Effects and Toxicity Studies
  • Chronic Kidney Disease and Diabetes

The scientist has contributed to a range of journals with frequent publications in:

  • Journal of the American Society of Nephrology
  • Kidney International Reports
  • Kidney International
  • Nephrology Dialysis Transplantation
  • Clinical and Experimental Nephrology

Notable recent papers by Masafumi Fukagawa include:

  • Prevalence of chronic kidney disease in Asia: a systematic review and analysis, 2022, BMJ Global Health
  • Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, 2022, Kidney International
  • Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, 2023, Kidney International
  • Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, 2023, Kidney International
  • Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis, 2021, JAMA

Masafumi Fukagawa has collaborated frequently with other researchers in related fields. Prominent coauthors include:

  • Hirotaka Komaba
  • Tadao Akizawa
  • Takayuki Hamano
  • Naohiko Fujii
  • Takahiro Imaizumi

Best Publications

  • Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters

    Markus Ketteler;Geoffrey A. Block;Pieter Evenepoel;Masafumi Fukagawa

  • Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

    N Fukuda;H Tanaka;Y Tominaga;M Fukagawa

  • p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase

    Hiroshi Watanabe;Yohei Miyamoto;Daisuke Honda;Hisae Tanaka

  • Clinical Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder

    Masafumi Fukagawa;Keitaro Yokoyama;Fumihiko Koiwa;Masatomo Taniguchi

  • Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

    Takashi Shigematsu;Junichiro James Kazama;Takeyoshi Yamashita;Seiji Fukumoto

  • Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.

    Francesca Tentori;Mia Wang;Brian A. Bieber;Angelo Karaboyas

  • Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update

    Markus Ketteler;Geoffrey A. Block;Pieter Evenepoel;Masafumi Fukagawa

  • Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients

    Hirotaka Komaba;Shunsuke Goto;Hideki Fujii;Yasuhiro Hamada

  • Cloning and characterization of developmental endothelial locus-1: An embryonic endothelial cell protein that binds the αvβ3 integrin receptor

    Chiaki Hidai;Thomas Zupancic;Kalyani Penta;Kalyani Penta;Adel Mikhail

  • Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients

    Shohei Nakanishi;Junichiro James Kazama;Tomoko Nii-Kono;Kentaro Omori

  • Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy.

    Kevin J Martin;Klaus Olgaard;Jack W Coburn;Jack W Coburn;Giorgio M Coen;Giorgio M Coen

  • Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells

    T Nii-Kono;Y Iwasaki;M Uchida;A Fujieda

  • Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients.

    Masafumi Fukagawa;Masafumi Kitaoka;Hung Yi;Naoko Fukuda

  • Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure.

    Junichiro J. Kazama;Takashi Shigematsu;Kazuki Yano;Eisuke Tsuda

  • Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism.

    Hirotaka Komaba;Masatomo Taniguchi;Atsushi Wada;Kunitoshi Iseki

  • Pirfenidone improves renal function and fibrosis in the post-obstructed kidney

    Toshikatsu Shimizu;Takayuki Kuroda;Satoshi Hata;Masafumi Fukagawa

  • Vitamin D Activates the Nrf2-Keap1 Antioxidant Pathway and Ameliorates Nephropathy in Diabetic Rats

    Kentaro Nakai;Hideki Fujii;Keiji Kono;Shunsuke Goto

  • Hypocalcemia increases and hypercalcemia decreases the steady-state level of parathyroid hormone messenger RNA in the rat.

    M Yamamoto;T Igarashi;M Muramatsu;M Fukagawa

  • FGF23-parathyroid interaction: implications in chronic kidney disease.

    Hirotaka Komaba;Masafumi Fukagawa;Masafumi Fukagawa

  • Role of oxidative stress in diabetic bone disorder.

    Yasuhiro Hamada;Hideki Fujii;Masafumi Fukagawa

Frequent Co-Authors

Shunichi Fukuhara
Shunichi Fukuhara Kyoto University
Toru Maruyama
Toru Maruyama Kumamoto University
Masaki Otagiri
Masaki Otagiri Sojo University
Takehiko Wada
Takehiko Wada Tohoku University
Ronald L. Pisoni
Ronald L. Pisoni Arbor Research Collaborative for Health
Sohei Kitazawa
Sohei Kitazawa Ehime University
Seiji Fukumoto
Seiji Fukumoto University of Tokushima
Fumitake Gejyo
Fumitake Gejyo Niigata University
Tilman B. Drüeke
Tilman B. Drüeke University of Paris-Saclay

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a wide range of healthcare careers beyond becoming a physician. For many, online degrees offer a flexible and affordable way to enter the health sector or advance in a current role.

Pharmacists, for example, are in high demand. Those considering this career path can now pursue online pharm d programs, allowing them to balance studies with other commitments. Nursing is another critical field, and those seeking advanced practice can look into the cheapest np school online options to become nurse practitioners.

Not all healthcare careers are patient-facing. Technology plays a vital role in modern medicine, and earning a health information technology online degree can lead to roles managing electronic health records and healthcare data systems.

For those interested in administrative and support positions, a medical coding certification can open doors to essential behind-the-scenes roles in billing and coding. Together, these pathways demonstrate the variety of rewarding careers available with online healthcare education.

Best Scientists Citing Masafumi Fukagawa

Trending Scientists